Advisor Group’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $203K | Sell |
8,546
-2,127
| -20% | -$50.5K | ﹤0.01% | 2382 |
|
|
2019
Q3 | $287K | Buy |
10,673
+1,371
| +15% | +$36.9K | ﹤0.01% | 2047 |
|
|
2019
Q2 | $252K | Buy |
9,302
+681
| +8% | +$18.4K | ﹤0.01% | 2126 |
|
|
2019
Q1 | $299K | Buy |
8,621
+3,305
| +62% | +$115K | ﹤0.01% | 1974 |
|
|
2018
Q4 | $105K | Sell |
5,316
-788
| -13% | -$15.6K | ﹤0.01% | 2617 |
|
|
2018
Q3 | $163K | Buy |
6,104
+1,246
| +26% | +$33.3K | ﹤0.01% | 2351 |
|
|
2018
Q2 | $183K | Buy |
4,858
+508
| +12% | +$19.1K | ﹤0.01% | 2045 |
|
|
2018
Q1 | $143K | Sell |
4,350
-639
| -13% | -$21K | ﹤0.01% | 2253 |
|
|
2017
Q4 | $243K | Buy |
4,989
+858
| +21% | +$41.8K | ﹤0.01% | 1838 |
|
|
2017
Q3 | $223K | Sell |
4,131
-2,369
| -36% | -$128K | ﹤0.01% | 1776 |
|
|
2017
Q2 | $365K | Sell |
6,500
-1,600
| -20% | -$89.8K | 0.01% | 1347 |
|
|
2017
Q1 | $317K | Sell |
8,100
-550
| -6% | -$21.5K | 0.01% | 1354 |
|
|
2016
Q4 | $194K | Sell |
8,650
-300
| -3% | -$6.73K | ﹤0.01% | 1571 |
|
|
2016
Q3 | $204K | Buy |
8,950
+6,202
| +226% | +$141K | ﹤0.01% | 1508 |
|
|
2016
Q2 | $63K | Buy |
+2,748
| New | +$63K | ﹤0.01% | 2244 |
|